Clinical Trials Logo

Clinical Trial Summary

The aim of this study is to assess the effect of Saccharomyces boulardii CNCM I-745 on gut microbiota in patients undergoing antibiotic therapy (in the context of erythema migrans (early skin form of Lyme borreliosis)).


Clinical Trial Description

The study is designed to compare the efficacy of Saccharomyces boulardii CNCM-I-745 500 mg bid to a placebo in patients undergoing antibiotic therapy in the context of erythema migrans as the early form of Lyme borreliosis. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06451913
Study type Interventional
Source Biocodex
Contact Laina N'DIAYE
Phone 03.44.86.82.28
Email l.n'diaye-ext@biocodex.fr
Status Not yet recruiting
Phase Phase 4
Start date June 2024
Completion date January 2025